I think a big issue is that the cash burn will be very high when 2591 goes through trials, to the point that if they are running multiple phase 3s, the company will be operating at a loss most likely.
If there's a lack of growth from the next Acadia update, I think it'll keep dropping.
NEU Price at posting:
$12.14 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)